MCF Advisors’s Neuronetics STIM Stock Holding History

MCF Advisors’s Portfolio STIM Stock Details STIM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.63K	Hold	3,564	–	–	﹤0.01%	1178
2026 Q1	$5.17K	Hold	3,564	–	–	﹤0.01%	1086
2025 Q4	$4.92K	Hold	3,564	–	–	﹤0.01%	946
2025 Q3	$9.73K	Hold	3,564	–	–	﹤0.01%	701
2025 Q2	$12.4K	Hold	3,564	–	–	﹤0.01%	617
2025 Q1	$13.1K	Sell	3,564 -2,000	-36%	-$7.3K	﹤0.01%	610
2024 Q4	$8.96K	Hold	5,564	–	–	﹤0.01%	676
2024 Q3	$4.23K	Hold	5,564	–	–	﹤0.01%	766
2024 Q2	$10K	Hold	5,564	–	–	﹤0.01%	641
2024 Q1	$26.5K	Hold	5,564	–	–	﹤0.01%	482
2023 Q4	$16.1K	Sell	5,564 -100	-2%	-$158	﹤0.01%	539
2023 Q3	$7.65K	Hold	5,664	–	–	﹤0.01%	613
2023 Q2	$12.2K	Hold	5,664	–	–	﹤0.01%	538
2023 Q1	$16.5K	Sell	5,664 -12,000	-68%	-$60.5K	﹤0.01%	501
2022 Q4	$121K	Buy	17,664 +5,000	+39%	+$23.6K	0.01%	250
2022 Q3	$40K	Sell	12,664 -2,900	-19%	-$10.5K	﹤0.01%	359
2022 Q2	$50K	Hold	15,564	–	–	0.01%	319
2022 Q1	$47K	Buy	+15,564	New	+$52.6K	﹤0.01%	336
2021 Q4	–	Sell	-26,564	Closed	-$174K	–	600
2021 Q3	$174K	Buy	26,564 +24,564	+1,228%	+$236K	0.02%	198
2021 Q2	$32K	Sell	2,000 -3,000	-60%	-$41.5K	﹤0.01%	338
2021 Q1	$62K	Buy	+5,000	New	+$76.6K	0.01%	251

Other funds holding STIM

MAM

Madryn Asset Management New York $36.9M AUM

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Wexford Capital West Palm Beach, Florida $782M AUM 62.56% 1-Year Est. Return

FCM

FourWorld Capital Management New York $110M AUM 44.07% 1-Year Est. Return

Lane Generational Dover, Massachusetts $114M AUM 43.8% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

MCM

Masters Capital Management Atlanta, Georgia $3.9B AUM 50.88% 1-Year Est. Return

AdvisorShares Investments Bethesda, Maryland $828M AUM 37.72% 1-Year Est. Return

Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

MCF Advisors's STIM Position: Q2 2026 in Review

MCF Advisors held its Neuronetics (STIM) position steady in Q2 2026 at 3,564 shares worth $4.63K. The position accounts for ﹤0.01% of the portfolio, ranked #1178.

MCF Advisors first reported a position in STIM in Q1 2021 and has held it in 21 quarters since. The position peaked at $174K in Q3 2021. 87 funds tracked by Wall St. Rank hold STIM as of Q2 2026.

MCF Advisors held 3,564 shares of Neuronetics worth $4.63K as of Q2 2026.
MCF Advisors left its Neuronetics share count unchanged in Q2 2026.
Neuronetics made up ﹤0.01% of MCF Advisors's portfolio in Q2 2026, its #1178 holding.
MCF Advisors first reported a position in Neuronetics in Q1 2021 and has held it in 21 quarters since.
MCF Advisors's Neuronetics position peaked at $174K in Q3 2021.
87 funds tracked by Wall St. Rank held Neuronetics as of Q2 2026.

Based on MCF Advisors's 13F filing for Q2 2026, filed 12 Aug 2026.